(EBOOK PDF) Pharmaceutical Innovation Incentives Competition and Cost Benefit Analysis in International Perspective 1st Edition by Frank Sloan, Chee Ruey Hsieh ISBN 0511282699 9780511282690 full chapters

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective 1st Edition by Frank A. Sloan, Chee-Ruey Hsieh – Ebook PDF Instant Download/Delivery: 0511282699, 9780511282690

Full download Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective 1st Edition after payment

 

 

Product details:

ISBN 10: 0511282699

ISBN 13: 9780511282690

Author: Frank A. Sloan, Chee-Ruey Hsieh

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective 1st Edition: The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.

 

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective 1st Edition Table of contents:

• Part I: The Industry Structure of Pharmaceutical Innovation

  • Chapter 2: The Pharmaceutical Sector in Health Care
  • Chapter 3: The Economics of Research and Development in the Pharmaceutical Industry

• Part II: Structuring Incentives for Research and Development

  • Chapter 4: Drugs for Neglected Diseases: New Incentives for Innovation
  • Chapter 5: When Patents Fail: Finding New Drugs for the Developing World
  • Chapter 6: Implementing a Public Subsidy for Vaccines
  • Chapter 7: Ensuring the Future Supply of Vaccines: Is a National Vaccine Authority the Answer?

• Part III: Competition and Marketing

  • Chapter 8: Competition Between Generic and Branded Drugs
  • Chapter 9: The United States’ Experience with Direct-to-Consumer Advertising of Prescription Drugs

• Part IV: Public Evaluation of the Benefits and Costs of Innovation

  • Chapter 10: Measures of Costs and Benefits for Drugs in Cost Effectiveness Analysis
  • Chapter 11: Using Economic Evaluation in Reimbursement Decisions for Health Technologies
  • Chapter 12: Pharmaceutical Spending and Health Outcomes
  • Chapter 13: Pharmaceutical Innovation and Health Outcomes: Empirical Evidence from Taiwan

 

People also search for Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective 1st Edition:

pharma innovation awards
    
pharma innovation awards 2022
    
innovation competitive advantage examples
    
incentives for pharmaceutical innovation
    
a pharmaceutical manufacturer offers monetary incentives

Tags:

Frank Sloan,Chee Ruey Hsieh,Pharmaceutical,Innovation,Incentives,Competition,Cost Benefit,Analysis,International,Perspective